Neurofibromatosis 1

Neurofibromatosis 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant condition caused by mutations in the NF1 gene. Here is the latest research.

September 5, 2020
Comment / Editorial
Open Access

Special Issue: "Genomics and Models of Nerve Sheath Tumors"

Genes
Angela C HirbeChristine A Pratilas
September 17, 2020

Breast cancer cell detection and characterization from breast milk-derived cells

Cancer Research
Poornima Bhat-NakshatriHarikrishna Nakshatri
September 2, 2020

Heritable susceptibility to breast cancer among African American women in the Detroit Research on Cancer Survivors Study

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Kristen S PurringtonAnn G Schwartz
August 26, 2020
Case Report

Neurofibromatosis type Ⅰwith parapharyngeal space invasion: report of one case

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
Yi HuLi Wang
August 31, 2020
Case Report
Open Access

'Adrenal rush' in a patient with Neurofibromatosis-1

Journal of Community Hospital Internal Medicine Perspectives
Samiha KhanJanki Patel
August 28, 2020

Cognitive functioning and pain interference mediate pain predictive effects on health-related quality of life in pediatric patients with Neurofibromatosis Type 1

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
James W VarniNancy L Swigonski
September 15, 2020

Further Lessons Learned From a Child With NF1 and Classical Hodgkin Lymphoma

Journal of Pediatric Hematology/oncology
Maria Carter FebresZeinab Afify
September 8, 2020

Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Eloïse BaudouYves Chaix
September 11, 2020

The Emerging Role of Ras Pathway Signaling in Pediatric Cancer

Cancer Research
Gina M NeyQing Li
September 12, 2020

MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level

American Journal of Translational Research
Shenglan LiWenbin Li
September 16, 2020

The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Caoimhe EganMark Raffeld

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurofibromatosis-1/4209b813-784f-44af-bf5b-1b0a9524525f